[Myocardiopathy diagnosed in utero in a mother with SS-A antibodies treated with plasmapheresis].
We report a 36 years old patient with Sjogren's syndrome, who during her second pregnancy, the product developed a miocardiopathy with complete heart block that was diagnosed in utero at 26 weeks of pregnancy. Simultaneously, laboratory data reported a SS-A/Ro titer of 1:50,000 with positive antiphospholipids antibodies. Patient was subjected three times to plasmapheresis with three blood volume exchange each time. During the procedures, we had monitor the product and no hemodinamic changes were observed. Unfortunately, 25 days later the patient reported absence of fetal movement and by ecosonography and Doppler was not observed fetal movement or cardiac function. This pregnancy ends in cesarea. The patient is in perfect clinical conditions under control using prednisone and methotrexate.
Arroyave
C M
CM
Hospital, Clínica, Maternidad Conchita, Monterrey, N.L.
Puente Ledezma
F
F
Montiel Amoroso
G
G
Martínez García
A C
AC
D000974:Antibodies, Antinuclear / Q000276:immunology; D002585:Cesarean Section; D015150:Echocardiography, Doppler; D005260:Female; D005313:Fetal Death; D006801:Humans; D007231:Infant, Newborn; D008727:Methotrexate / Q000627:therapeutic use; D009205:Myocarditis / Q000175:diagnosis*; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications; D012859:Sjogren's Syndrome / Q000188:drug therapy / Q000276:immunology; D016216:Ultrasonography, Prenatal
D000974:Antibodies, Antinuclear; D011241:Prednisone; D008727:Methotrexate
Miocardiopatía diagnosticada in utero en madre con anticuerpos contra SS-A tratada con plasmaféresis.